{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:59:15Z","timestamp":1787597955368,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T00:00:00Z","timestamp":1536364800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"DBT-India","award":["[BT\/PR19713\/BIC\/101\/237\/2016]"],"award-info":[{"award-number":["[BT\/PR19713\/BIC\/101\/237\/2016]"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10495-018-1485-4","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T13:27:00Z","timestamp":1536413220000},"page":"679-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Molecular targeting of breast and colon cancer cells by PAR1 mediated apoptosis through a novel pro-apoptotic peptide"],"prefix":"10.1007","volume":"23","author":[{"given":"Tanusree","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwiprohi","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravanti","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrima","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,8]]},"reference":[{"key":"1485_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/967347","author":"J Thundimadathil","year":"2012","unstructured":"Thundimadathil J (2012) Cancer treatment using peptides: current therapies and future prospects. J Amino Acids. https:\/\/doi.org\/10.1155\/2012\/967347","journal-title":"J Amino Acids"},{"issue":"3","key":"1485_CR2","first-page":"419","volume":"26","author":"CE J\u00e4kel","year":"2012","unstructured":"J\u00e4kel CE, Meschenmoser K, Kim Y, Weiher H, Schmidt-Wolf IG (2012) Efficacy of a proapoptotic peptide towards cancer cells. In Vivo 26(3):419\u2013426","journal-title":"In Vivo"},{"key":"1485_CR3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1201\/9781420039658","volume-title":"Anticancer agents from natural products","author":"GM Cragg","year":"2005","unstructured":"Cragg GM, Kingston D, Newman DJ (2005) Anticancer agents from natural products. Brunner-Routledge Psychology Press, London, pp\u00a0186\u2013205"},{"key":"1485_CR4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/np030096l","volume":"66","author":"DJ Newman","year":"2003","unstructured":"Newman DJ, Cragg GM, Snader KM (2003) Natural products as a source of new drugs over the period 1981\u20132002. J Nat Prod 66:1022\u20131037. https:\/\/doi.org\/10.1021\/np030096l","journal-title":"J Nat Prod"},{"issue":"4","key":"1485_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1042\/BST0350780","volume":"35","author":"J Enb\u00a8ack","year":"2007","unstructured":"Enb\u00a8ack J, Laakkonen P (2007) Tumour-homing peptides: tools for targeting, imaging and destruction. Biochem Soc Trans 35(4):780\u2013783. https:\/\/doi.org\/10.1042\/BST0350780","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"1485_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/bip.10257","volume":"66","author":"OH Aina","year":"2002","unstructured":"Aina OH, Sroka TC, Chen ML, Lam KS (2002) Therapeutic cancer targeting peptides. Biopolymers 66(3):184\u2013199. https:\/\/doi.org\/10.1002\/bip.10257","journal-title":"Biopolymers"},{"issue":"1\u20132","key":"1485_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","volume":"15","author":"P Vlieghe","year":"2010","unstructured":"Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010) Synthetic therapeutic peptides: science and market. Drug Discov Today 15(1\u20132):40\u201356. https:\/\/doi.org\/10.1016\/j.drudis.2009.10.009","journal-title":"Drug Discov Today"},{"issue":"8","key":"1485_CR8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nbt1320","volume":"25","author":"XQ Qiu","year":"2007","unstructured":"Qiu XQ, Wang H, Cai B, Wang LL, Yue ST (2007) Small antibody mimetics comprising two complementarity-determining regions and a framework region for tumor targeting. Nat Biotechnol 25(8):921\u2013929. https:\/\/doi.org\/10.1038\/nbt1320","journal-title":"Nat Biotechnol"},{"key":"1485_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc903","volume":"2","author":"TM Allen","year":"2002","unstructured":"Allen TM (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2:750\u2013763. https:\/\/doi.org\/10.1038\/nrc903","journal-title":"Nat Rev Cancer"},{"key":"1485_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrc1891","volume":"6","author":"I Pastan","year":"2006","unstructured":"Pastan I, Hassan R, Fitzgerald DJ, Kreitman RJ (2006) Immunotoxin therapy of cancer. Nat Rev Cancer 6:559\u2013565. https:\/\/doi.org\/10.1038\/nrc1891","journal-title":"Nat Rev Cancer"},{"key":"1485_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1158\/1078-0432.CCR-0642-03","volume":"10","author":"PE Thorpe","year":"2004","unstructured":"Thorpe PE (2004) Vascular targeting agents as cancer therapeutics. Clin Cancer Res 10:415\u2013427. https:\/\/doi.org\/10.1158\/1078-0432.CCR-0642-03","journal-title":"Clin Cancer Res"},{"issue":"19","key":"1485_CR12","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.2174\/1381612043383944","volume":"10","author":"T Mori","year":"2004","unstructured":"Mori T (2004) Cancer-specific ligands identified from screening of peptide-display libraries. Curr Pharm Des 10(19):2335\u20132343. https:\/\/doi.org\/10.2174\/1381612043383944","journal-title":"Curr Pharm Des"},{"issue":"2","key":"1485_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/107327480200900207","volume":"9","author":"ME Reff","year":"2002","unstructured":"Reff ME, Hariharan K, Braslawsky G (2002) Future of monoclonal antibodies in the treatment of hematologic malignancies. Cancer Control 9(2):152\u2013166. https:\/\/doi.org\/10.1177\/107327480200900207","journal-title":"Cancer Control"},{"issue":"22","key":"1485_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/cen-v089n022.p013","volume":"89","author":"AM Thayer","year":"2011","unstructured":"Thayer AM (2011) Improving peptides. Chem Eng News 89(22):13\u201320. https:\/\/doi.org\/10.1021\/cen-v089n022.p013","journal-title":"Chem Eng News"},{"issue":"11","key":"1485_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/psc.717","volume":"11","author":"C Borghouts","year":"2005","unstructured":"Borghouts C, Kunz C, Groner B (2005) Current strategies for the development of peptide-based anti-cancer therapeutics. J Pept Sci 11(11):713\u2013726. https:\/\/doi.org\/10.1002\/psc.717","journal-title":"J Pept Sci"},{"issue":"2","key":"1485_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10495-015-1194-1","volume":"21","author":"T Ray","year":"2016","unstructured":"Ray T, Chakrabarti MK, Pal A (2016) Hemagglutinin protease secreted by V. cholerae induced apoptosis in breast cancer cells by ROS mediated intrinsic pathway and regresses tumor growth in mice model. Apoptosis 21(2):143\u2013154. https:\/\/doi.org\/10.1007\/s10495-015-1194-1","journal-title":"Apoptosis"},{"key":"1485_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/ol.2011.291","volume":"2","author":"N Han","year":"2011","unstructured":"Han N, Jin K, He K, Cao J, Teng L (2011) Protease-activated receptors in cancer: a systematic review. Oncol Lett 2:599\u2013608. https:\/\/doi.org\/10.3892\/ol.2011.291","journal-title":"Oncol Lett"},{"issue":"2","key":"1485_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1476-5381.2010.00705.x","volume":"160","author":"UJ Soh","year":"2010","unstructured":"Soh UJ, Dores MR, Chen B, Trejo J (2010) Signal transduction by protease-activated receptors. Br J Pharmacol 160(2):191\u2013203. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00705.x","journal-title":"Br J Pharmacol"},{"issue":"7","key":"1485_CR19","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/emboj.2012.42","volume":"31","author":"B Turk","year":"2012","unstructured":"Turk B, Turk D, Turk V (2012) Protease signalling: the cutting edge. EMBO J 31(7):1630\u20131643. https:\/\/doi.org\/10.1038\/emboj.2012.42","journal-title":"EMBO J"},{"key":"1485_CR20","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/1535-7163.MCT-08-0177","volume":"7","author":"A Agarwal","year":"2008","unstructured":"Agarwal A, Covic L, Sevigny LM, Kaneider NC, Lazarides K, Azabdaftari G et al (2008) Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer. Mol Cancer Ther 7:2746\u20132757. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0177","journal-title":"Mol Cancer Ther"},{"key":"1485_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cell.2004.12.018","volume":"120","author":"A Boire","year":"2005","unstructured":"Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120:303\u2013313. https:\/\/doi.org\/10.1016\/j.cell.2004.12.018","journal-title":"Cell"},{"key":"1485_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1006\/bbrc.2001.5823","volume":"288","author":"S Pal","year":"2001","unstructured":"Pal S, Choudhuri T, Chattopadhyay S, Bhattacharya A, Datta GK, Das T et al (2001) Mechanisms of curcumin-induced apoptosis of Ehrlich\u2019s ascites carcinoma cells. Biochem Biophys Res Commun 288:658\u2013665. https:\/\/doi.org\/10.1006\/bbrc.2001.5823","journal-title":"Biochem Biophys Res Commun"},{"key":"1485_CR23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00262-002-0288-0","volume":"51","author":"T Das","year":"2002","unstructured":"Das T, Sa G, Chattopadhyay S, Ray PK (2002) Protein A-induced apoptosis of cancer cells is affected by soluble immune mediators. Cancer Immunol Immunother 51:376\u2013380. https:\/\/doi.org\/10.1007\/s00262-002-0288-0","journal-title":"Cancer Immunol Immunother"},{"key":"1485_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/329456a0","volume":"329","author":"JV Gannon","year":"1987","unstructured":"Gannon JV, Lane DP (1987) p63 and DNA polymerase a compete for the binding to SV40 T antigen. Nature 329:456\u2013458","journal-title":"Nature"},{"issue":"19","key":"1485_CR25","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1093\/hmg\/ddn192","volume":"17","author":"M Rosner","year":"2008","unstructured":"Rosner M, Hengstschlager M (2008) Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum Mol Genet 17(19):2934\u20132948. https:\/\/doi.org\/10.1093\/hmg\/ddn192","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1485_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10495-016-1229-2","volume":"21","author":"T Ray","year":"2016","unstructured":"Ray T, Pal A (2016) PAR-1 mediated apoptosis of breast cancer cells by V.cholerae hemagglutinin protease. Apoptosis 21(5):609\u2013620. https:\/\/doi.org\/10.1007\/s10495-016-1229-2","journal-title":"Apoptosis"},{"issue":"4","key":"1485_CR27","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1128\/JCM.41.4.1548-1557.2003","volume":"41","author":"T Kageyama","year":"2003","unstructured":"Kageyama T, Kojima S, Shinohara M, Uchida K, Fukushi S, Hoshino FB, Takeda N, Katayama K (2003) Broadly reactive and highly sensitive assay for norwalk-like viruses based on real-time Quantitative reverse transcription-PCR. J Clin Microbiol 41(4):1548\u20131557","journal-title":"J Clin Microbiol"},{"key":"1485_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/carcin\/bgh067","volume":"25","author":"H Kumagai","year":"2004","unstructured":"Kumagai H, Mukaisho K, Sugihara H, Miwa K, Yamamoto G, Hattori T (2004) Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats. Carcinogenesis 25:723\u2013727. https:\/\/doi.org\/10.1093\/carcin\/bgh067","journal-title":"Carcinogenesis"},{"key":"1485_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6750-5-12","volume":"10","author":"D Ribble","year":"2005","unstructured":"Ribble D, Goldstein NB, Norris DA, Shellman YG (2005) A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 10:5\u201312. https:\/\/doi.org\/10.1186\/1472-6750-5-12","journal-title":"BMC Biotechnol"},{"issue":"8","key":"1485_CR30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.5551\/jat.2881","volume":"17","author":"T Ray","year":"2010","unstructured":"Ray T, Maity PC, Banerjee S, Deb S, Dasgupta AK, Sarkar S et al (2010) Vitamin C prevents cigarette smoke induced atherosclerosis in guinea pig model. J Atheroscler Thromb 17(8):817\u2013827. https:\/\/doi.org\/10.5551\/jat.2881","journal-title":"J Atheroscler Thromb"},{"key":"1485_CR31","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1038\/ncomms7169","volume":"6","author":"B Majumder","year":"2015","unstructured":"Majumder B, Baraneedharan U, Thiyagarajan S, Radhakrishnan P, Narashisimhan H, Dhandapani M et al (2015) Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity. Nat Commun 6:6169. https:\/\/doi.org\/10.1038\/ncomms7169","journal-title":"Nat Commun"},{"key":"1485_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1023\/A:1013512912160","volume":"7","author":"S Chattopadhyay","year":"2002","unstructured":"Chattopadhyay S, Das T, Sa G, Ray PK (2002) Protein A-activated macrophages induce apoptosis in Ehrlich\u2019s ascites carcinoma through a nitric oxide-dependent pathway. Apoptosis 7:49\u201357","journal-title":"Apoptosis"},{"issue":"1","key":"1485_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/carcin\/24.1.75","volume":"24","author":"A Bhattacharyya","year":"2003","unstructured":"Bhattacharyya A, Choudhuri T, Pal S, Chattopadhyay S, Datta GK, Sa G et al (2003) Apoptogenic effects of black tea on Ehrlich\u2019s ascites carcinoma cell. Carcinogenesis 24(1):75\u201380. https:\/\/doi.org\/10.1093\/carcin\/24.1.75","journal-title":"Carcinogenesis"},{"issue":"1\u20132","key":"1485_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2007.03.011","volume":"186","author":"T Roy","year":"2007","unstructured":"Roy T, Paul S, Baral RN, Chattopadhyay U, Biswas R (2007) Tumor associated release of interleukin-10 alters the prolactin receptor and down-regulates prolactin responsiveness of immature cortical thymocytes. J Neuroimmunol 186(1\u20132):112\u2013120. https:\/\/doi.org\/10.1016\/j.jneuroim.2007.03.011","journal-title":"J Neuroimmunol"},{"key":"1485_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong RS (2011) Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 30:87. https:\/\/doi.org\/10.1186\/1756-9966-30-87","journal-title":"J Exp Clin Cancer Res"},{"key":"1485_CR36","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm0898-909","volume":"4","author":"S Even-Ram","year":"1998","unstructured":"Even-Ram S, Uziely B, Cohen P et al (1998) Thrombin receptor over expression in malignant and physiological invasion processes. Nat Med 4:909\u2013914","journal-title":"Nat Med"},{"key":"1485_CR37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1158\/1541-7786.395.2.7","volume":"2","author":"X Shi","year":"2004","unstructured":"Shi X, Gangadharan B, Brass L, Ruf W, Mueller B (2004) Protease activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2:395\u2013402","journal-title":"Mol Cancer Res"},{"issue":"914","key":"1485_CR38","doi-asserted-by":"publisher","first-page":"10952","DOI":"10.1074\/jbc.M007027200","volume":"276","author":"SC Even-Ram","year":"2001","unstructured":"Even-Ram SC, Maoz M, Pokroy E, Reich R, Katz BZ, Gutwein P, Altevogt P, Bar-Shavit R (2001) Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the \u03b1v\u03b25 integrin. J Biol Chem 276(914):10952\u201310962. https:\/\/doi.org\/10.1074\/jbc.M007027200","journal-title":"J Biol Chem"},{"key":"1485_CR39","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1021\/bi9824792","volume":"38","author":"A Kuliopulos","year":"1999","unstructured":"Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J, Costello CE (1999) Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38:4572\u20134585. https:\/\/doi.org\/10.1021\/bi9824792","journal-title":"Biochemistry"},{"key":"1485_CR40","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.1073\/pnas.96.20.11023","volume":"96","author":"SR Coughlin","year":"1999","unstructured":"Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023\u201311027. https:\/\/doi.org\/10.1073\/pnas.96.20.11023","journal-title":"Proc Natl Acad Sci USA"},{"key":"1485_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1042\/bj20030346","volume":"375","author":"CJ Chalmers","year":"2003","unstructured":"Chalmers CJ, Balmanno K, Hadfield K, Ley R, Cook SJ (2003) Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1. Biochem J 375:99\u2013109. https:\/\/doi.org\/10.1042\/bj20030346","journal-title":"Biochem J"},{"key":"1485_CR42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1023\/B:APPT.0000045784.49886.96","volume":"6","author":"AN Flynn","year":"2004","unstructured":"Flynn AN, Buret AG (2004) Proteinase-activated receptor 1 (PAR-1) and cell apoptosis. Apoptosis 6:729\u2013737. https:\/\/doi.org\/10.1023\/B:APPT.0000045784.49886.96","journal-title":"Apoptosis"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-018-1485-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-018-1485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-018-1485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T23:50:40Z","timestamp":1661989840000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-018-1485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,8]]},"references-count":42,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1007\/s10495-018-1485-4","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,8]]},"assertion":[{"value":"8 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mice were maintained as per the principles and guidelines of the ethical committee for animal care of National Institute of Cholera and Enteric Diseases (NICED). The experimental design of the present study was approved by Institutional Animal Ethics Committee (License No: PRO\/136\/December 2016-December 2019), NICED, Kolkata, India.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animals and ethics statement"}}]}}